Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole added to progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF
ChiCTR-IPR-17014076Phase 4Recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of letrozole, human menopausal gonadotrophin and medroxyprogesterone acetate in infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: number of oocytes retrieved and luteinizing hormone value. Started Jan 2018; status: recruiting.
02
Drugs
letrozolehuman menopausal gonadotrophinmedroxyprogesterone acetate
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-IPR-17014076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17014076.